New Test Helps Evaluate Cancer Drug’s Merit
MONDAY, July 9 (HealthDay News) — A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration. Read More..
July 11th, 2012
Posted in
Drug